VUMC in the news

Again this week, growing concern about the coronavirus that began in Wuhan, China, and has now spread to many other countries, including the U.S., has brought numerous members of the local, national and international press to request interviews with William Schaffner, MD, professor of Preventive Medicine, Buddy Creech, associate professor of Pediatrics, Tom Talbot, MD, MPH, Chief Hospital Epidemiologist for VUMC, and Mark Denison, MD, professor of Pediatrics and director of the Division of Pediatric Infectious Diseases.
A small sampling of a few of the most prominent includes:
- NBC News segment with Schaffner answering questions from people on the street in downtown Nashville.
- The New York Times (Schaffner)
- NBC News (Denison)
- Reuters (Schaffner)
- Vox (Schaffner)
- WZTV Fox 17 News (Creech)
- The Tennessean (Talbot)
- The Wall Street Journal (Schaffner)
- Time (Schaffner)
- U.S. News and World Report (Schaffner)
- WSMV News 4 (Denison)
In addition, Yahoo Sports features writer Henry Bushnell and The Wall Street Journal sports reporter Ben Cohen interviewed Schaffner for stories on the coronavirus and its potential impact on the 2020 Olympics, scheduled for this summer in Japan. Schaffner and Creech were also interviewed for stories for CNN, The Independent, China Daily, and other outlets about this year’s flu season, and how it is unusually deadly for children.
Stat senior science writer Sharon Begley interviewed Timothy Hohman, PhD, associate professor of Neurology in the Vanderbilt Memory & Alzheimer’s Center, for a story about his research that looks at resilience to Alzheimer’s disease.
Psychology Today featured an article written by Stephen Camarata, PhD, professor of Hearing & Speech Sciences at the Vanderbilt Bill Wilkerson Center, about breakthroughs in language and literacy in children who are born deaf.
“CBS This Morning” medical producer Angelica Fusco interviewed Cassie Brady, MD, assistant professor of Clinical Pediatrics, for a story about an 8-year-old girl who has central precocious puberty and needs a treatment to slow her hormones. A company makes two identical hormone implant drugs (Vantas and Supprelin) and is charging quadruple the price for the pediatric version.

